Xoma Ltd. Chairman, President and CEO Steven Engle stepped down Wednesday from all of the positions as the company struggles to move past disappointing results from a diabetes trial earlier this year.
The Berkeley company (NASDAQ: XOMA) said current board member John Varian will become interim CEO and W. Denman Van Ness, Xoma’s lead independent director, will become chairman. Xoma will start looking for a permanent CEO.
No comments:
Post a Comment